Results 171 to 180 of about 236,951 (253)
Aims CYP2C19 is one of the most important pharmacogenes, and its activity is highly variable due to factors such as genetics or drug–drug interactions. Due to the lack of an appropriate endogenous CYP2C19 biomarker, surrogate methods to assess its activity are warranted.
Julian Peter Müller +9 more
wiley +1 more source
Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883).
Hager ElGeed +7 more
wiley +1 more source
Revealing transport kinetics for efficient electrochemical conversion of captured CO<sub>2</sub> in amine solutions. [PDF]
Lv Z, Liu K, Yin CQ, Du L, Liu M, Hu XM.
europepmc +1 more source
One‐Pot Synthesis of a Small Synthetic Ligand for Antibody Purification
One‐pot liquid‐phase synthesis of the synthetic ligand B1Al2A2 enables controllable ligand density and efficient capture of IgG and IgY with high recovery and purity, streamlining small‐ligand affinity purification workflows. ABSTRACT The development of synthetic affinity ligands offers a cost‐effective alternative to traditional biological ligands ...
Carolina Mota Natal +8 more
wiley +1 more source
Hydrogeochemical processes and water quality of the Aïn Taga Karst Spring, Tlemcen, Northwestern Algeria. [PDF]
Guettaia S +7 more
europepmc +1 more source
ABSTRACT Chinese hamster ovary (CHO) cells are the leading host for recombinant therapeutic protein production in the biopharma industry. In this study, we investigated how feeding acidic forms of tricarboxylic acid (TCA) cycle intermediates—malic acid, succinic acid, and α‐ketoglutaric acid—affects cell culture performance and metabolism in two ...
Sarah A. Sacco +8 more
wiley +1 more source
Updates in Hospital Medicine: Nephrology. [PDF]
Garsuta CGL, Mahmoud HM, Gordon LB.
europepmc +1 more source
ABSTRACT Modern biopharmaceutical manufacturing requires purification platforms capable of processing structurally and functionally diverse products while addressing the challenge of removing persistent and high‐risk host cell proteins (HCPs).
Wenning Chu +23 more
wiley +1 more source
Non‐model plants: Challenges and solutions
Applications in Plant Sciences, EarlyView.
José M. Cunill‐Flores +2 more
wiley +1 more source

